Chatham Capital Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.41M | Sell |
25,486
-725
| -3% | -$156K | 0.82% | 34 |
|
|
2026
Q1 | $5.7M | Sell |
26,211
-925
| -3% | -$205K | 0.83% | 31 |
|
|
2025
Q4 | $6.2M | Sell |
27,136
-875
| -3% | -$199K | 0.88% | 28 |
|
|
2025
Q3 | $6.49M | Sell |
28,011
-2,440
| -8% | -$497K | 0.93% | 27 |
|
|
2025
Q2 | $5.65M | Sell |
30,451
-4,562
| -13% | -$848K | 0.86% | 32 |
|
|
2025
Q1 | $7.34M | Sell |
35,013
-1,459
| -4% | -$284K | 1.22% | 23 |
|
|
2024
Q4 | $6.48M | Buy |
36,472
+360
| +1% | +$66.2K | 1.07% | 25 |
|
|
2024
Q3 | $7.13M | Buy |
36,112
+3,985
| +12% | +$744K | 1.17% | 21 |
|
|
2024
Q2 | $5.51M | Buy |
32,127
+1,022
| +3% | +$169K | 0.96% | 30 |
|
|
2024
Q1 | $5.66M | Sell |
31,105
-93
| -0.3% | -$16K | 1.04% | 29 |
|
|
2023
Q4 | $4.83M | Sell |
31,198
-490
| -2% | -$71.4K | 0.98% | 29 |
|
|
2023
Q3 | $4.72M | Sell |
31,688
-168
| -0.5% | -$24.7K | 1.05% | 27 |
|
|
2023
Q2 | $4.29M | Sell |
31,856
-400
| -1% | -$58.7K | 0.9% | 33 |
|
|
2023
Q1 | $5.14M | Sell |
32,256
-1,015
| -3% | -$155K | 1.15% | 25 |
|
|
2022
Q4 | $5.38M | Sell |
33,271
-8,043
| -19% | -$1.23M | 1.26% | 23 |
|
|
2022
Q3 | $5.54M | Sell |
41,314
-61
| -0.1% | -$8.75K | 1.36% | 20 |
|
|
2022
Q2 | $6.34M | Sell |
41,375
-168
| -0.4% | -$25.7K | 1.43% | 20 |
|
|
2022
Q1 | $6.73M | Sell |
41,543
-2,415
| -5% | -$351K | 1.3% | 24 |
|
|
2021
Q4 | $5.95M | Sell |
43,958
-2,575
| -6% | -$304K | 1.07% | 28 |
|
|
2021
Q3 | $5.02M | Sell |
46,533
-4,148
| -8% | -$474K | 0.97% | 31 |
|
|
2021
Q2 | $5.71M | Sell |
50,681
-2,472
| -5% | -$278K | 1.1% | 27 |
|
|
2021
Q1 | $5.75M | Sell |
53,153
-3,325
| -6% | -$356K | 1.2% | 23 |
|
|
2020
Q4 | $6.05M | Sell |
56,478
-96
| -0.2% | -$9.22K | 1.36% | 19 |
|
|
2020
Q3 | $4.96M | Sell |
56,574
-2,660
| -4% | -$250K | 1.22% | 23 |
|
|
2020
Q2 | $5.82M | Sell |
59,234
-2,475
| -4% | -$218K | 1.51% | 16 |
|
|
2020
Q1 | $4.7M | Sell |
61,709
-80
| -0.1% | -$6.81K | 1.39% | 18 |
|
|
2019
Q4 | $5.47M | Sell |
61,789
-1,090
| -2% | -$90.5K | 1.35% | 22 |
|
|
2019
Q3 | $4.76M | Sell |
62,879
-5,500
| -8% | -$377K | 1.22% | 24 |
|
|
2019
Q2 | $4.97M | Sell |
68,379
-955
| -1% | -$75.1K | 1.25% | 25 |
|
|
2019
Q1 | $5.59M | Sell |
69,334
-2,750
| -4% | -$225K | 1.44% | 22 |
|
|
2018
Q4 | $6.64M | Sell |
72,084
-4,600
| -6% | -$405K | 1.85% | 14 |
|
|
2018
Q3 | $7.25M | Buy |
76,684
+750
| +1% | +$71.1K | 1.83% | 15 |
|
|
2018
Q2 | $7.04M | Sell |
75,934
-75
| -0.1% | -$7.33K | 1.85% | 17 |
|
|
2018
Q1 | $7.19M | Sell |
76,009
-2,385
| -3% | -$262K | 1.93% | 15 |
|
|
2017
Q4 | $7.58M | Sell |
78,394
-1,540
| -2% | -$145K | 2.09% | 14 |
|
|
2017
Q3 | $7.1M | Sell |
79,934
-1,830
| -2% | -$139K | 2.01% | 14 |
|
|
2017
Q2 | $5.93M | Sell |
81,764
-2,550
| -3% | -$171K | 1.64% | 19 |
|
|
2017
Q1 | $5.49M | Buy |
84,314
+3,716
| +5% | +$234K | 1.53% | 20 |
|
|
2016
Q4 | $5.05M | Sell |
80,598
-1,617
| -2% | -$98.7K | 1.47% | 21 |
|
|
2016
Q3 | $5.18M | Sell |
82,215
-13,041
| -14% | -$844K | 1.64% | 18 |
|
|
2016
Q2 | $5.9M | Buy |
95,256
+23,465
| +33% | +$1.43M | 1.82% | 15 |
|
|
2016
Q1 | $4.1M | Buy |
71,791
+1,250
| +2% | +$69.7K | 1.29% | 24 |
|
|
2015
Q4 | $4.18M | Sell |
70,541
-765
| -1% | -$44.1K | 1.34% | 23 |
|
|
2015
Q3 | $3.88M | Buy |
71,306
+1,730
| +2% | +$113K | 1.31% | 24 |
|
|
2015
Q2 | $4.67M | Sell |
69,576
-400
| -0.6% | -$26.1K | 1.32% | 24 |
|
|
2015
Q1 | $4.1M | Sell |
69,976
-300
| -0.4% | -$18.1K | 1.2% | 27 |
|
|
2014
Q4 | $4.6M | Sell |
70,276
-200
| -0.3% | -$12.6K | 1.37% | 21 |
|
|
2014
Q3 | $4.07M | Buy |
70,476
+1,285
| +2% | +$71.3K | 1.26% | 24 |
|
|
2014
Q2 | $3.9M | Buy |
69,191
+1,750
| +3% | +$91.8K | 1.53% | 28 |
|
|
2014
Q1 | $3.47M | Buy |
67,441
+300
| +0.4% | +$15.2K | 1.43% | 27 |
|
|
2013
Q4 | $3.55M | Buy |
67,141
+200
| +0.3% | +$9.83K | 1.48% | 26 |
|
|
2013
Q3 | $2.99M | Buy |
66,941
+460
| +0.7% | +$20.4K | 1.36% | 30 |
|
|
2013
Q2 | $2.75M | Buy |
+66,481
| New | +$2.91M | 1.34% | 27 |
|
Other funds holding ABBV
Chatham Capital Group's ABBV Position: Q2 2026 in Review
Chatham Capital Group reduced its AbbVie (ABBV) stake by 2.8% in Q2 2026, selling an estimated $156K and leaving 25,486 shares worth $6.41M. The position accounts for 0.82% of the portfolio, ranked #34.
Chatham Capital Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.58M in Q4 2017. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Chatham Capital Group held 25,486 shares of AbbVie worth $6.41M as of Q2 2026.
- Chatham Capital Group sold 725 AbbVie shares in Q2 2026, an estimated $156K.
- AbbVie made up 0.82% of Chatham Capital Group's portfolio in Q2 2026, its #34 holding.
- Chatham Capital Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Chatham Capital Group's AbbVie position peaked at $7.58M in Q4 2017.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.